Panasonic Receives Highest Award of Brand Design at the Automotive Brand Contest 2020
On June 30, 2020, Panasonic Corporation announced that it has received the highest accolade as Best of Best in the Brand Design category at the Automotive Brand Contest 2020, which is organized by German Design Council (Rat für Formgebung). The award was given in recognition of the concept and design of the Panasonic Automotive business brand. The official award ceremony is planned to take place in autumn 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200629005891/en/
Panasonic Automotive's brand design that received the highest award of brand design at the Automotive Brand Contest 2020 (Graphic: Business Wire)
The Automotive Brand Contest is the only international design competition for automotive brands. The German Design Council, founded in 1953, also runs internationally renowned design awards, such as the German Design Award and the ICONIC Awards.
The Automotive Brand Contest covers all creative aspects in the automotive industry across the world – from vehicle design to corporate publishing. This year's winners also include global brands, such as Audi, BMW, Buick, Byton, Continental, Mercedes-Benz, Porsche and Volkswagen. Panasonic is the first Japanese automotive supplier to be awarded Best of Best in the contest’s history which started in 2011.
In praise of Panasonic Automotive’s brand design, the contest jury said, “The consistent appearance in light blue and green unobtrusively underscores the clear positioning of the Panasonic Automotive brand, where it transitions from a vision into reality, from innovation to automotive solutions, thus becoming convincingly tangible.”
The development of the brand’s concept and design was initiated in Europe from the spring of 2017. The process adopted a collaborative approach with clients. Brand concept and design was developed through basing on clients’ image and expectation on Panasonic. Additionally, several options were reviewed by clients as well as automotive media persons before making the final decision.
Panasonic Automotive’s brand concept and design is adopted not only in Europe but also globally, including China and Japan. It was first presented at its booth at the Shanghai Motor Show in April 2019.
Panasonic continues to strive to enhance the recognition and understandings of its automotive business through the Panasonic Automotive brand and increase the brand value of the company.
About Panasonic
Panasonic Corporation is a global leader developing innovative technologies and solutions for wide-ranging applications in the consumer electronics, housing, automotive, and B2B sectors. The company, which celebrated its 100th anniversary in 2018, operates 528 subsidiaries and 72 associated companies worldwide and reported consolidated net sales of 7.49 trillion yen for the year ended March 31, 2020. Committed to pursuing new value through collaborative innovation, the company uses its technologies to create a better life and a better world for customers. Learn more about Panasonic: https://www.panasonic.com/global.
Source: https://news.panasonic.com/global/topics/2020/79235.html
Related Links
Automotive Company, Panasonic Corporation
https://www.panasonic.com/global/corporate/am.html
Panasonic Business Brands
https://www.panasonic.com/global/corporate/brand/our-brand/business_brand.html
Automotive Brand Contest 2020
https://www.automotive-brand-contest.de/en.html
[Press Release] Toyota and Panasonic Decide to Establish Joint Venture Specializing in Automotive Prismatic Batteries (Feb 3, 2020)
https://news.panasonic.com/global/press/data/2020/02/en200203-4/en200203-4.html
[Press Release] Panasonic Develops a Driverless Automated Valet Parking System and a Large Screen AR-HUD (Oct 11, 2019)
https://news.panasonic.com/global/press/data/2019/10/en191011-2/en191011-2.html
[Press Release] Panasonic to Showcase Booth at 26th ITS World Congress Singapore 2019 (Oct 10, 2019)
https://news.panasonic.com/global/press/data/2019/10/en191010-3/en191010-3.html
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200629005891/en/
Contact information
Panasonic Corporation
Global Communications Department
Global PR Office
Click here to go to Media Contact form
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom